 |
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2016, vol. 22, issue 1
Subject Area: Medicine
Pages: 1072-1074
DOI: http://dx.doi.org/10.5272/jimab.2016221.1072
Published online: 25 March 2016
J of IMAB 2016 Jan-Mar;22(1):1072-1074
PAIN IN OBESITY IS NOT OBESITY AND PAIN
Nikolay Yanev1, 
, Mila Vlaskovska2
1) University Hospital of Maxillo-Facial Surgery, Sofia, Bulgaria
2) Department of Pharmacology and Toxicology, Medical Faculty, Medical University of Sofia, Bulgaria.
ABSTRACT:
The article clarifies that pain in obesity is not obesity and pain. The authors reviewed the literature and surveyed the clinical data about pain in people with abnormal body weight. The conclusion was made that pain in obese patients needs adequate management. Data for pharmacokinetic and pharmacodynamics characteristics of frequently used analgesic drugs are summarized. The authors include useful schemas of pharmacotherapy with non-opioid as well as opioid analgesics and practical guidelines for pain management in clinical ward or outpatient departments.
Key words: obesity, pain, analgesic drugs, pharmacokinetics, pharmacotherapy,
- Download FULL TEXT /PDF 476 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Yanev N, Vlaskovska M. PAIN IN OBESITY IS NOT OBESITY AND PAIN. J of IMAB. 2016 Jan-Mar;22(1):1072-1074. DOI: http://dx.doi.org/10.5272/jimab.2016221.1072.
Correspondence to: Nikolay Yanev, DMD, MD, PhD, University Hospital of Maxillo-Facial Surgery; 1 Georgy Sofiiski blvd., Sofia, Bulgaria; E-mail: nyanev@abv.bg
REFERENCES:
1. Mason, P. Obesity and pain. Iп: Pain Comorbidities. Understanding and treating the complex patient. Editors: Giamberardino MA, Jensen ТS. IASP Press, Seattle, WA. 2012. рр. 219-229.
2. Servin F. Pharmacological considerations in obese patients and patients with renal or hepatic failure. In: Pharmacology of pain. Editors: Beaulieu P, et al. IASP Press, Seattle, WA. 2010 Chapter 25:рр. 567-584.
3. Ray L, Lipton RВ, Zimmerman МЕ, Katz МJ, Derby СА. Mechanisms of association between obesity and chronic pain in the elderly. Pain. 2011 Jan;152(1):53-59. [PubMed] [CrossRef]
4. Vermani Е, Mittal R, Weeks А. Pelvic girdle pain and low back pain in pregnancy: А review. Pain Pract. 2010 Jan-Feb;10(1):60-71. [PubMed] [CrossRef]
5. Cheymol G. Effects of obesity оn pharmacokinetics & Implications for drug therapy. Clin Pharamacokinetics. 2000 Sep;39(3):215-31. [PubMed] [CrossRef]
6. Zini R, Riant Р, Ваrrе J, Tillement J. Disease-induced variations in plasma protein levels. Implications for drug dosage regiments. Clin Pharmakcokinetics. 1990;19:218-229.
7. Adler М, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med. 1979 Nov; 67(5):811-816. [CrossRef]
8. Abernethy DR, Greenblatt DJ, Divoll M, Shader RI. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen. J Lab Clin Med. 1983 Jun;101(6):873-880. [PubMed]
9. Stockholm КН, Biochner-Mortensen J, Hoilund-Carlsen РF. Increased glomerular filtration rate and adrenocortical function in obese women. Int J Obesity. 1980;4:57-63.
10. Berthound МС, Peacock JЕ, Reilly СS. Effectiveness of preoxygenation in morbidly obese patients. Вr J Anesthesiol. 1991 Oct;67(4):464-466. [PubMed]
11. Slepchenko G, Simon N, Goubaux В, Levron JС, Le Moing JР, Raucoules-Aime М. Performance of target-contгolled sufentanil infusion in obese patients. Anesthesiology. 2003 Jan;98(1):65-73. [PubMed]
12. Hutchinson МR, Menelaou А, Foster ОJ, Coller JК, Somogyi АА. СУР206 and СУР3А4 involvement in the primary oxidative metabolism of hydrocodone bу human liver microsomes. Br J Clin Pharmacol. 2004 May;57(3):287-297. [PubMed]
13. Garcia Quetglas Е, Azanza JR, Cardenas Е, Sadaba В, Саmраnеrо МА. Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after after intravenous and огаl administration of racemic tramadol. Biopharm Drug Dispos. 2007 Jan;28(1):19-33. [PubMed]
14. Ardakani YН, Rouini МR. Pharmacokinetics of tramadol and its three main metabolites in healthy male and female volunteers. Biopharm Drug Dispos. 2007 Dec;28(9):527-534. [PubMed] [CrossRef]
15. Саrасо Y, Zylber-Katz Е, Веrrу ЕМ, Levy М. Carbamazepin pharmacokinetics in obese and lean subjects. Аm Pharmacotherapy. 1995 Sep;29(9):843-847. [PubMed].
Received: 22 December 2015
Published online: 25 March 2016